Medicap Promine
Natural health product licensed in Canada
- Other names
- PROMINE
- Licence holder
- Biowell Laboratories
- NPN or DIN-HM
- 80082742
- Status
- Active licence
- Licence date
- 30 January 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 400 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 4 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Diglycinate de zinc | 25 mg | 50,000 µg |
| Ginkgo biloba Source : Feuille Potency : 24 % Flavonoid glycosides | Not specified | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 3,500 mg Potency : 6 % Terpene lactones | 70 mg | Not calculated |
| Magnésium Source : Aspartate de magnésium | 100 mg | 200,000 µg |
| Chrome Source : Picolinate de chrome (III) | 200 mcg | 400 µg |
| Vitamine B6 Source : Pyridoxine | 2 mg | 4,000 µg |
| Thiamine Source : Thiamine | 1.5 mg | 3,000 µg |
| Silybum marianum Source : Fruit Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 2,100 mg Potency : 80 % Silymarin | 70 mg | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 200 mg | Not calculated |
| Vanadium Source : Sulfate de vanadyle | 90 mcg | Not calculated |
| Niacine Source : Niacinamide | 13 mg | Not calculated |
| Acide L-ascorbique Source : Acide ascorbique | 60 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of good health. Helps to enhance cognitive function and memory in adults. Helps to support peripheral circulation. Used in Herbal Medicine as a hepatoprotectant/ liver protectant and also help relieve digestive disturbances/dyspepsia. Helps the body to metabolize carbohydrates and fats. Provides support for healthy glucose metabolism. Helps in the development and maintenance of bones, teeth, hair, nail and skin. Helps in tissue formation and proper muscle function including the heart muscle. Helps to maintain normal DNA synthesis. Helps to maintain normal acid-base metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80082742
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.